Literature DB >> 21235356

Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness.

Elisa Giannoni1, Francesca Bianchini, Lido Calorini, Paola Chiarugi.   

Abstract

Cancer-associated fibroblasts (CAFs) are key determinants in the malignant progression of cancer, supporting tumorigenesis and metastasis. CAFs also mediate epithelial mesenchymal transition (EMT) of tumor cells and their achievement of stem cell traits. We demonstrate that CAFs induce EMT and stemness through a proinflammatory signature, which exploits reactive oxygen species to drive a migratory and aggressive phenotype of prostate carcinoma cells. CAFs exert their propelling role for EMT in strict dependence on cycloxygenase-2 (COX-2), nuclear factor-κB, and hypoxia-inducible factor-1. CAF-secreted metalloproteases elicit in carcinoma cells a Rac1b/COX-2-mediated release of reactive oxygen species, which is mandatory for EMT, stemness, and dissemination of metastatic cells. Tumor growth is abolished, and metastasis formation is severely impaired by RNA interfering-mediated targeting of the proinflammatory signature, thereby supporting the therapeutic targeting of the circuitry COX-2/nuclear factor-κB /hypoxia-inducible factor-1 as a valuable antimetastatic tool affecting cancer cell malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235356     DOI: 10.1089/ars.2010.3727

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  80 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

2.  A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

Authors:  Melanie J Grubisha; M E Cifuentes; Stephen R Hammes; Donald B Defranco
Journal:  Mol Endocrinol       Date:  2012-05-16

3.  Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.

Authors:  Tania Fiaschi; Elisa Giannoni; Maria Letizia Taddei; Paolo Cirri; Alberto Marini; Gianfranco Pintus; Cristina Nativi; Barbara Richichi; Andrea Scozzafava; Fabrizio Carta; Eugenio Torre; Claudiu T Supuran; Paola Chiarugi
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

4.  DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.

Authors:  C Pistore; E Giannoni; T Colangelo; F Rizzo; E Magnani; L Muccillo; G Giurato; M Mancini; S Rizzo; M Riccardi; N Sahnane; V Del Vescovo; K Kishore; M Mandruzzato; F Macchi; M Pelizzola; M A Denti; D Furlan; A Weisz; V Colantuoni; P Chiarugi; I M Bonapace
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

Review 5.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

6.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

Review 7.  Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships.

Authors:  Abigail Hielscher; Sharon Gerecht
Journal:  Free Radic Biol Med       Date:  2014-10-22       Impact factor: 7.376

Review 8.  Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition.

Authors:  Jeffrey T Chang; Sendurai A Mani
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

9.  EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.

Authors:  Elisa Giannoni; Maria Letizia Taddei; Matteo Parri; Francesca Bianchini; Michela Santosuosso; Renata Grifantini; Gabriella Fibbi; Benedetta Mazzanti; Lido Calorini; Paola Chiarugi
Journal:  J Mol Med (Berl)       Date:  2012-08-19       Impact factor: 4.599

10.  Senescent stroma promotes prostate cancer progression: the role of miR-210.

Authors:  Maria Letizia Taddei; Lorenzo Cavallini; Giuseppina Comito; Elisa Giannoni; Marco Folini; Alberto Marini; Paolo Gandellini; Andrea Morandi; Gianfranco Pintus; Maria Rosaria Raspollini; Nadia Zaffaroni; Paola Chiarugi
Journal:  Mol Oncol       Date:  2014-07-21       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.